These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15305245)

  • 1. The use of methotrexate in rheumatoid arthritis.
    Borchers AT; Keen CL; Cheema GS; Gershwin ME
    Semin Arthritis Rheum; 2004 Aug; 34(1):465-83. PubMed ID: 15305245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
    Bergstra SA; Allaart CF; Stijnen T; Landewé RBM
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1473-1483. PubMed ID: 27992656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utrecht experience with different treatment strategies in early rheumatoid arthritis.
    Verstappen SM; Jacobs JW; Bijlsma JW;
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S165-8. PubMed ID: 14969070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
    Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH
    Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
    Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
    Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial.
    Genovese MC; Tena CP; Covarrubias A; Leon G; Mysler E; Keiserman M; Valente R; Nash P; Simon-Campos JA; Box J; Legerton CW; Nasonov E; Durez P; Delaet I; Teng J; Alten R
    J Rheumatol; 2014 Apr; 41(4):629-39. PubMed ID: 24584926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
    Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
    Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in rheumatoid arthritis.
    Swierkot J; Szechiński J
    Pharmacol Rep; 2006; 58(4):473-92. PubMed ID: 16963793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.
    Xia Z; Lyu J; Hou N; Song L; Li X; Liu H
    Z Rheumatol; 2016 Oct; 75(8):828-833. PubMed ID: 26508503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Gaujoux-Viala C; Rincheval N; Dougados M; Combe B; Fautrel B
    Ann Rheum Dis; 2017 Dec; 76(12):2054-2060. PubMed ID: 28866645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
    Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E
    Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
    Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
    J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low dose methotrexate therapy in chronic polyarthritis--an update].
    Leeb BF; Smolen JS
    Acta Med Austriaca; 1996; 23(4):114-9. PubMed ID: 9036721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
    Barrera P; van der Maas A; van Ede AE; Kiemeney BA; Laan RF; van de Putte LB; van Riel PL
    Rheumatology (Oxford); 2002 Apr; 41(4):430-9. PubMed ID: 11961174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of methotrexate in the treatment of rheumatoid arthritis.
    Yazici Y
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S65-7. PubMed ID: 21044436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.